NC DAC Fall Meeting New Diabetes Medications and Diabetes Poster Session 2025

October 3, 2025

The Diabetes Advisory Council (DAC) of North Carolina was created in 1984 as an advisory group to the Diabetes Prevention and Control program. It is comprised of physicians, diabetes care and education specialists, registered dieticians, pharmacists, nurses, nurse practitioners, health educators, exercise physiologists. The DAC works to reduce the burden of diabetes through coordination among the many collaborators in diabetes control in North Carolina. Core responsibilities are to 1) educate about benefits of early detection, treatment and self-management training for diabetes control, as a health priority for all North Carolinians; 2) review and educate members, the public, health care providers, and lawmakers about scientific evidence regarding clinical, epidemiological, and technology advances in diabetes care, 3) Evaluate, present and propose strategies for the control of diabetes in North Carolina in terms of assessed need, estimated costs, potential benefits and probability of success of each strategy. On Friday October 3rd, we will have UNC Professor of Medicine Dr John Buse present on new diabetes medications soon to be available or in the research pipeline. We will also have a poster session. Thus far the posters submitted have been: 1. Successful Use of Technosphere Insulin (Inhaled insulin) From Clinical Research to Clinical Practice Kevin Kaiserman, MD, Joann Rinker RD, 2. Inhaled Insulin in Pediatric Diabetes Results of the INHALE-1 Trial; Kevin Kaiserman, MD, Joann Rinker RD, 3. Inhaled Insulin reduces Post Meal Hyperglycemia in Pediatrics Study; Thomas Blevins, MD, Kevin Kaiserman, MD, Joann Rinker RD, 4. Diabetes and Prediabetes Alerts at Duke Health Susan Spratt, MD and Michele Casey, MD 5. Engaging Inpatient Nursing Staff to be Curious About Diabetes Technology With Hands-on Education, Chris E. Memering, MSN, RN, CDCES, BC-ADM, FADCES Beth Cesaro, MSN, RN 6. Feasibility and Acceptability of a Novel Telehealth Personalized Group Visit Program for Patients with Type 2 Diabetes with A1c Not at Goal: A Pilot Study, Roshini Srinivasan MD, Felicia Williams MD MS, Christie Clipper DHA, Susan Spratt MD, Samir Soneji, PhD, Ralph Snyderman MD

Target Audience

Allied Health Professionals

Audiologists

Fellows

Medical Students

Nurses

Nurse Practitioners

Physicians

Physician Assistants

Pharmacy Technicians

Pharmacists

Residents

Learning Objectives

Learning about new drugs available for the treatment of diabetes including pharmacology, mechanism of action, risk/benefits for new treatments of diabetes.

Understanding ways to disseminate knowledge about new therapies (nurse/ provider education, new models of care, clinical decision support)

Course summary
Available credit: 
  • 2.50 ACPE - Pharmacist
  • 2.50 ACPE - Pharmacy Technician
  • 2.50 AMA PRA Category 1 Credit(s)
  • 2.50 ANCC
  • 2.50 Attendance
  • 0.25 IACET CEU
  • 2.50 JA Credit - AH
Registration Opens: 
10/03/2025
Registration Expires: 
10/02/2026
Activity Starts: 
10/03/2025 - 9:00am EDT
Activity Ends: 
10/03/2025 - 12:30pm EDT
Rating: 
5

ACPE - Pharmacy Technician

ACPE - Pharmacist

AMA PRA Category 1 Credit(s)

ANCC

Attendance

IACET CEU

JA Credit - AH

Available Credit

  • 2.50 ACPE - Pharmacist
  • 2.50 ACPE - Pharmacy Technician
  • 2.50 AMA PRA Category 1 Credit(s)
  • 2.50 ANCC
  • 2.50 Attendance
  • 0.25 IACET CEU
  • 2.50 JA Credit - AH
Please login or register to take this course.